...
首页> 外文期刊>Molecular vision >Novel compound heterozygous mutations in MYO7A in a Chinese family with Usher syndrome type 1
【24h】

Novel compound heterozygous mutations in MYO7A in a Chinese family with Usher syndrome type 1

机译:中国家庭Usher综合征1型MYO7A的新型复合杂合突变。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To identify the disease-causing mutation(s) in a Chinese family with autosomal recessive Usher syndrome type 1 (USH1). Methods: An ophthalmic examination and an audiometric test were conducted to ascertain the phenotype of two affected siblings. The microsatellite marker D11S937, which is close to the candidate gene MYO7A (USH1B locus), was selected for genotyping. From the DNA of the proband, all coding exons and exon-intron boundaries of MYO7A were sequenced to identify the disease-causing mutation(s). Restriction fragment length polymorphism (RFLP) analysis was performed to exclude the alternative conclusion that the mutations are non-pathogenic rare polymorphisms. Results: Based on severe hearing impairment, unintelligible speech, and retinitis pigmentosa, a clinical diagnosis of Usher syndrome type 1 was made. The genotyping results did not exclude the USH1B locus, which suggested that the MYO7A gene was likely the gene associated with the disease-causing mutation(s) in the family. With direct DNA sequencing of MYO7A, two novel compound heterozygous mutations (c.3742GA and c.6051+1GA) of MYO7A were identified in the proband. DNA sequence analysis and RFLP analysis of other family members showed that the mutations cosegregated with the disease. Unaffected members, including the parents, uncle, and sister of the proband, carry only one of the two mutations. The mutations were not present in the controls (100 normal Chinese subjects=200 chromosomes) according to the RFLP analysis. Conclusions: In this study, we identified two novel mutations, c.3742GA (p.E1248K) and c.6051+1GA (donor splice site mutation in intron 44), of MYO7A in a Chinese non-consanguineous family with USH1. The mutations cosegregated with the disease and most likely cause the phenotype in the two affected siblings who carry these mutations compound heterozygously. Our finding expands the mutational spectrum of MYO7A.
机译:目的:确定患有常染色体隐性遗传性亚瑟氏综合征1型(USH1)的中国家庭的致病突变。方法:进行眼科检查和听力测试,以确定两个患病兄弟姐妹的表型。选择与候选基因MYO7A(USH1B基因座)接近的微卫星标记D11S937进行基因分型。从先证者的DNA,对MYO7A的所有编码外显子和外显子-内含子边界进行测序,以鉴定致病突变。进行限制性片段长度多态性(RFLP)分析,以排除该突变是非病原性罕见多态性的替代结论。结果:基于严重的听力障碍,语言不清和色素性视网膜炎,对1型Usher综合征进行了临床诊断。基因分型结果并未排除USH1B基因座,这表明MYO7A基因可能是与该家庭中致病突变相关的基因。通过对MYO7A进行直接DNA测序,在先证者中鉴定出MYO7A的两个新的复合杂合突变(c.3742G> A和c.6051 + 1G> A)。 DNA序列分析和其他家庭成员的RFLP分析表明,突变与疾病共分离。未受影响的成员,包括先证者的父母,叔叔和妹妹,仅携带两个突变之一。根据RFLP分析,在对照(100名正常中国人= 200条染色体)的对照中不存在突变。结论:在这项研究中,我们确定了一个中国非血缘性家庭的MYO7A的两个新突变,即c.3742G> A(p.E1248K)和c.6051 + 1G> A(内含子44的供体剪接位点突变)。 USH1。突变与疾病共隔离,并且最有可能在携带这些突变的两个受影响的同胞中杂合地产生表型。我们的发现扩大了MYO7A的突变谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号